What is MMED's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 5.55B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for MMED?

P/E (TTM) is n/a and 52-week range is $10.65 to $24.43 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s MMED figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

Where is MiniMed Group Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Northridge, California, US, 280.8M shares outstanding, ISIN US60365F1093 when available from company profile and filing metadata.

MiniMed Group Inc

$MMED

Health Care · Health Care Equipment & Supplies

Run Scenarios

$19.71

-0.45%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. The company is headquartered in Northridge, California and currently employs 8,000 full-time employees. The company went IPO on 2026-03-06. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.

Employees

8,000

IPO

2026-03-06

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (TTM)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

US60365F1093

Headquarters

Northridge, California, US

Shares outstanding

280.8M

NAICS sector

Manufacturing

Institutional ownership

13.35%